From guideline to clinic: diagnostic imaging workflows in dermatology

Abstract

Emerging evidence indicates that patient selection criteria deserve closer scrutiny, a finding echoed by several independent groups. From a workflow perspective, patient selection criteria deserve closer scrutiny, which has direct implications for daily practice. Recent studies suggest that pre-analytical factors account for a large share of observed variance, a finding echoed by several independent groups. According to consensus recommendations, standardized reporting improves comparability between centers, with meaningful differences between subgroups.

Longitudinal data show that early intervention correlates with better long-term outcomes, particularly in resource-constrained settings. Across multiple cohorts, integrating quantitative measures reduces subjective bias, as discussed in the accompanying commentary.

Background

According to consensus recommendations, cross-disciplinary review changes the initial assessment in a sizeable minority of cases, with meaningful differences between subgroups. Contrary to earlier assumptions, variability between operators remains a key limitation, particularly in resource-constrained settings. Recent studies suggest that digital tooling shortens time-to-decision considerably, and this trend is expected to continue. Emerging evidence indicates that patient selection criteria deserve closer scrutiny, which has direct implications for daily practice. Emerging evidence indicates that patient selection criteria deserve closer scrutiny, particularly in resource-constrained settings.

Limitations

According to consensus recommendations, variability between operators remains a key limitation, which has direct implications for daily practice. In multidisciplinary settings, real-world registries complement randomized trial evidence, as discussed in the accompanying commentary. From a workflow perspective, pre-analytical factors account for a large share of observed variance, as discussed in the accompanying commentary.

What the evidence shows

Recent studies suggest that pre-analytical factors account for a large share of observed variance, with meaningful differences between subgroups. Recent studies suggest that real-world registries complement randomized trial evidence, and this trend is expected to continue. Across multiple cohorts, threshold harmonization is still an open question, and this trend is expected to continue. From a workflow perspective, training and accreditation are decisive for reproducibility, although confirmatory data are still limited.

Emerging evidence indicates that training and accreditation are decisive for reproducibility, and this trend is expected to continue. Contrary to earlier assumptions, threshold harmonization is still an open question, and this trend is expected to continue. Longitudinal data show that threshold harmonization is still an open question, although confirmatory data are still limited. In routine practice, cost considerations continue to shape adoption in smaller units, a finding echoed by several independent groups. According to consensus recommendations, cost considerations continue to shape adoption in smaller units, with meaningful differences between subgroups.